Advertisement
Screener

DELCATH SYSTEMS, INC. (DCTH) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price

1.8 / 5 stars · 26/74 Roast Me

DELCATH SYSTEMS, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price

DELCATH SYSTEMS, INC. (DCTH) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $5.58 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-08-06

  • DELCATH SYSTEMS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2026-03-31 was $5.30, a 14.52% decline year-over-year.
  • DELCATH SYSTEMS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2025-03-31 was $6.20.
  • DELCATH SYSTEMS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $7.54, a 20.83% increase from fiscal 2024.
  • DELCATH SYSTEMS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $6.24, a 33.62% increase from fiscal 2023.
  • DELCATH SYSTEMS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $4.67.
  • DELCATH SYSTEMS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2021 was $9.85.
Period endShare-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month
2026-06-30$5.58
10-Q · filed 2026-08-06
2026-03-31$5.30
10-Q · filed 2026-05-07
2025-12-31$7.54
10-K · filed 2026-02-26
2025-09-30$7.59
10-Q · filed 2025-11-04
2025-06-30$6.14
10-Q · filed 2025-08-06
2025-03-31$6.20
10-Q · filed 2025-05-08
2024-12-31$6.24
10-K · filed 2025-03-06
2024-09-30$5.19
10-Q · filed 2024-11-08
2024-06-30$5.22
10-Q · filed 2024-08-05
2023-12-31$4.67
10-K · filed 2024-03-26
2023-09-30$4.67
10-Q · filed 2023-11-13
2023-06-30$4.67
10-Q · filed 2023-08-09
2021-12-31$9.85
10-K · filed 2022-03-31
2011-12-31$3.18
10-K · filed 2013-03-13
2010-12-31$3.52
10-K · filed 2013-03-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
SS Innovations International, Inc. (SSII)$0.589B-64.06
CERUS CORP (CERS)United States$0.525B-86.40
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
NeuroPace Inc (NPCE)United States$0.480B-28.52
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
CARLSMED, INC. (CARL)United States$0.405B